Skip to main content
Erschienen in: Rheumatology International 10/2011

01.10.2011 | Review

Coexistence of vasculitides with Familial Mediterranean Fever

verfasst von: Kenan Aksu, Gokhan Keser

Erschienen in: Rheumatology International | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Abstract

Familial Mediterranean fever (FMF) is the most common autoinflammatory disease characterized by recurrent self-limited attacks of fever accompanied with peritonitis, pleuritis, or arthritis. FMF may coexist with various systemic inflammatory diseases including vasculitides, spondyloarthritis, multiple sclerosis, and inflammatory bowel disease. Among these coexistences, this review concentrates on vasculitic disorders, with the aim of increasing the awareness of FMF-vasculitis association. This association does not merely show a coincidentally increased frequency of vasculitic disorders in FMF; rather, it seems that FMF patients might be at increased risk of developing vasculitis. Indeed, as also suggested by some authors, vasculitis might be an essential feature of FMF. Among the vasculitic disorders reported to be associated with FMF, Henoch–Schönlein purpura, and classical polyarteritis nodosa come the first, possibly followed up by protracted febrile myalgia. There is also an ongoing debate whether Behçet’s disease (BD) more frequently seen in FMF than expected by chance alone. In this review, the associations of various vasculitic disorders with FMF and the possible pathogenic mechanisms underlying these associations, as well as the frequencies and clinical significances of FMF-related MEFV mutations in various vasculitides including BD, are discussed in the context of the available data.
Literatur
1.
Zurück zum Zitat Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 28(351):659–664CrossRef Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 28(351):659–664CrossRef
3.
Zurück zum Zitat Ben-Chetrit E, Touitou I (2009) Familial Mediterranean Fever in the world. Arthritis Rheum 61:1447–1453PubMedCrossRef Ben-Chetrit E, Touitou I (2009) Familial Mediterranean Fever in the world. Arthritis Rheum 61:1447–1453PubMedCrossRef
4.
Zurück zum Zitat French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31CrossRef French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31CrossRef
5.
Zurück zum Zitat Aksentijevich I, Torosyan Y, Samuels J et al (1999) Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 64:949–962PubMedCrossRef Aksentijevich I, Torosyan Y, Samuels J et al (1999) Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 64:949–962PubMedCrossRef
6.
Zurück zum Zitat Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 27(2 Suppl 53):S29–S31PubMed Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 27(2 Suppl 53):S29–S31PubMed
7.
Zurück zum Zitat Ozdogan H, Arisoy N, Kasapcopur O et al (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327PubMed Ozdogan H, Arisoy N, Kasapcopur O et al (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327PubMed
8.
Zurück zum Zitat Hatemi G, Masatlioglu S, Gogus F, Ozdogan H (2004) Necrotizing vasculitis associated with familial Mediterranean fever. Am J Med 117:516–519PubMedCrossRef Hatemi G, Masatlioglu S, Gogus F, Ozdogan H (2004) Necrotizing vasculitis associated with familial Mediterranean fever. Am J Med 117:516–519PubMedCrossRef
9.
Zurück zum Zitat Flatau E, Kohn D, Schiller D, Lurie M, Levy E (1982) Schönlein-Henoch syndrome in patients with familial Mediterranean fever. Arthritis Rheum 25:42–47PubMedCrossRef Flatau E, Kohn D, Schiller D, Lurie M, Levy E (1982) Schönlein-Henoch syndrome in patients with familial Mediterranean fever. Arthritis Rheum 25:42–47PubMedCrossRef
10.
Zurück zum Zitat Schlesinger M, Rubinow A, Vardy PA (1985) Henoch-Schönlein purpura and familial Mediterranean fever. Isr J Med Sci 21:83–85PubMed Schlesinger M, Rubinow A, Vardy PA (1985) Henoch-Schönlein purpura and familial Mediterranean fever. Isr J Med Sci 21:83–85PubMed
11.
Zurück zum Zitat Sachs D, Langevitz P, Morag B, Pras M (1987) Polyarteritis nodosa and familial Mediterranean fever. Br J Rheumatol 26:139–141PubMedCrossRef Sachs D, Langevitz P, Morag B, Pras M (1987) Polyarteritis nodosa and familial Mediterranean fever. Br J Rheumatol 26:139–141PubMedCrossRef
12.
Zurück zum Zitat Glikson M, Galun E, Schlesinger M et al (1989) Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature. J Rheumatol 16:536–539PubMed Glikson M, Galun E, Schlesinger M et al (1989) Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature. J Rheumatol 16:536–539PubMed
13.
Zurück zum Zitat Tunca M, Akar S, Onen F, Turkish FMF Study Group et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRef Tunca M, Akar S, Onen F, Turkish FMF Study Group et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRef
14.
Zurück zum Zitat Ozcakar ZB, Yalcinkaya F, Cakar N et al (2008) MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura. J Rheumatol 35:2427–2429PubMedCrossRef Ozcakar ZB, Yalcinkaya F, Cakar N et al (2008) MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura. J Rheumatol 35:2427–2429PubMedCrossRef
15.
Zurück zum Zitat Yalcinkaya F, Ozcakar ZB, Kasapcopur O et al (2007) Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 151:675–678PubMedCrossRef Yalcinkaya F, Ozcakar ZB, Kasapcopur O et al (2007) Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 151:675–678PubMedCrossRef
16.
Zurück zum Zitat Langevitz P, Zemer D, Livneh A et al (1994) Protracted febrile myalgia in patients with familial Mediterranean fever. J Rheumatol 21:1708–1709PubMed Langevitz P, Zemer D, Livneh A et al (1994) Protracted febrile myalgia in patients with familial Mediterranean fever. J Rheumatol 21:1708–1709PubMed
17.
Zurück zum Zitat Schwartz T, Langevitz P, Zemer D et al (2000) Behçet’s disease in Familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29:286–295PubMedCrossRef Schwartz T, Langevitz P, Zemer D et al (2000) Behçet’s disease in Familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29:286–295PubMedCrossRef
18.
Zurück zum Zitat Birlik M, Tunca M, Hizli N et al (1998) Coexistence of familial Mediterranean fever with sacroiliitis and Behçet’s disease: a rare occurrence. Clin Rheumatol 17:397–399PubMedCrossRef Birlik M, Tunca M, Hizli N et al (1998) Coexistence of familial Mediterranean fever with sacroiliitis and Behçet’s disease: a rare occurrence. Clin Rheumatol 17:397–399PubMedCrossRef
19.
Zurück zum Zitat Ben-Chetrit E, Yazici H (2002) Thoughts on the proposed links between Behçet’s disease and familial Mediterranean fever. Clin Exp Rheumatol 20(4 Suppl 26):S1–S2PubMed Ben-Chetrit E, Yazici H (2002) Thoughts on the proposed links between Behçet’s disease and familial Mediterranean fever. Clin Exp Rheumatol 20(4 Suppl 26):S1–S2PubMed
20.
Zurück zum Zitat Atagunduz P, Ergun T, Direskeneli H (2003) MEFV mutations are increased in Behçet’s disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 21(4 Suppl 30):S35–S37PubMed Atagunduz P, Ergun T, Direskeneli H (2003) MEFV mutations are increased in Behçet’s disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 21(4 Suppl 30):S35–S37PubMed
21.
Zurück zum Zitat Ayesh S, Abu-Rmaileh H, Nassar S et al (2008) Molecular analysis of MEFV gene mutations among Palestinian patients with Behcet’s disease. Scand J Rheumatol 37:370–374PubMedCrossRef Ayesh S, Abu-Rmaileh H, Nassar S et al (2008) Molecular analysis of MEFV gene mutations among Palestinian patients with Behcet’s disease. Scand J Rheumatol 37:370–374PubMedCrossRef
22.
Zurück zum Zitat Padeh S, Shinar Y, Pras E et al (2003) Clinical and diagnostic value of genetic testing in 216 Israeli children with Familial Mediterranean fever. J Rheumatol 30:185–190PubMed Padeh S, Shinar Y, Pras E et al (2003) Clinical and diagnostic value of genetic testing in 216 Israeli children with Familial Mediterranean fever. J Rheumatol 30:185–190PubMed
23.
Zurück zum Zitat Ureten K, Gönülalan G, Akbal E et al (2010) Demographic, clinical and mutational characteristics of Turkish familial Mediterranean fever patients: results of a single center in Central Anatolia. Rheumatol Int 30:911–915PubMedCrossRef Ureten K, Gönülalan G, Akbal E et al (2010) Demographic, clinical and mutational characteristics of Turkish familial Mediterranean fever patients: results of a single center in Central Anatolia. Rheumatol Int 30:911–915PubMedCrossRef
24.
Zurück zum Zitat Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81PubMedCrossRef Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81PubMedCrossRef
25.
Zurück zum Zitat Ben-Zvi I, Livneh A (2011) Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nature Review Rheum 7:105–112CrossRef Ben-Zvi I, Livneh A (2011) Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nature Review Rheum 7:105–112CrossRef
26.
Zurück zum Zitat Lachmann HJ, Sengul B, Yavuzsen TU et al (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45:746–750CrossRef Lachmann HJ, Sengul B, Yavuzsen TU et al (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45:746–750CrossRef
27.
Zurück zum Zitat Cattan D (2005) MEFV mutation carriers and diseases other than familial mediterranean fever: proved and non-proved associations; putative biological advantage. Current Drug Targets Inflamm Allergy 4:105–112CrossRef Cattan D (2005) MEFV mutation carriers and diseases other than familial mediterranean fever: proved and non-proved associations; putative biological advantage. Current Drug Targets Inflamm Allergy 4:105–112CrossRef
28.
Zurück zum Zitat Samuels J, Ozen S (2006) Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18:108–117PubMedCrossRef Samuels J, Ozen S (2006) Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18:108–117PubMedCrossRef
29.
Zurück zum Zitat Yang X-F, Yin Y, Wang H (2008) Vascular inflammation and atherogenesis are activated via receptors for PAMPs and suppressed by regulatory T cells. Drug Discov Today Ther Strateg 5:125–142PubMedCrossRef Yang X-F, Yin Y, Wang H (2008) Vascular inflammation and atherogenesis are activated via receptors for PAMPs and suppressed by regulatory T cells. Drug Discov Today Ther Strateg 5:125–142PubMedCrossRef
30.
Zurück zum Zitat Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550PubMedCrossRef Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550PubMedCrossRef
31.
Zurück zum Zitat Dinarello CA (2009) Interleukin-1β and the autoinflammatory diseases. N Engl J Med 360(23):2467–2470PubMedCrossRef Dinarello CA (2009) Interleukin-1β and the autoinflammatory diseases. N Engl J Med 360(23):2467–2470PubMedCrossRef
32.
Zurück zum Zitat Rafiq S, Stevens K, Hurst AJ et al (2007) Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun 8:344–351PubMedCrossRef Rafiq S, Stevens K, Hurst AJ et al (2007) Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun 8:344–351PubMedCrossRef
33.
Zurück zum Zitat Keller M, Ruegg A, Werner S et al (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132:818–831PubMedCrossRef Keller M, Ruegg A, Werner S et al (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132:818–831PubMedCrossRef
34.
Zurück zum Zitat Nickel W, Rabouille C (2009) Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 10:148–155PubMedCrossRef Nickel W, Rabouille C (2009) Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 10:148–155PubMedCrossRef
35.
Zurück zum Zitat Ye Z, Ting JP (2008) NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr Opin Immunol 20:3–9PubMedCrossRef Ye Z, Ting JP (2008) NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr Opin Immunol 20:3–9PubMedCrossRef
36.
Zurück zum Zitat Aypar E, Ozen S, Okur H et al (2003) Th1 polarization in familial mediterranean fever. J Rheumatol 30:2011–2013PubMed Aypar E, Ozen S, Okur H et al (2003) Th1 polarization in familial mediterranean fever. J Rheumatol 30:2011–2013PubMed
37.
Zurück zum Zitat Simsek I, Pay S, Pekel A et al (2007) Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int 27:807–811PubMedCrossRef Simsek I, Pay S, Pekel A et al (2007) Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int 27:807–811PubMedCrossRef
38.
Zurück zum Zitat Manukyan G, Ghazaryan K, Ktsoyan Z et al (2010) Comparative analysis of cytokine profiles in autoinflammatory and autoimmune conditions. Cytokine 50:146–151PubMedCrossRef Manukyan G, Ghazaryan K, Ktsoyan Z et al (2010) Comparative analysis of cytokine profiles in autoinflammatory and autoimmune conditions. Cytokine 50:146–151PubMedCrossRef
39.
Zurück zum Zitat Grau GE, Roux-Lombard P, Gysler C et al (1989) Serum cytokine changes in systemic vasculitis. Immunology 68:196–198PubMed Grau GE, Roux-Lombard P, Gysler C et al (1989) Serum cytokine changes in systemic vasculitis. Immunology 68:196–198PubMed
40.
Zurück zum Zitat Saadoun D, Bieche I, Authier FJ et al (2007) Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 56:1315–1324PubMedCrossRef Saadoun D, Bieche I, Authier FJ et al (2007) Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 56:1315–1324PubMedCrossRef
41.
Zurück zum Zitat Freire Ade L, Bertolo MB, de Pinho AJ Jr et al (2004) Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet’s disease. Clin Rheumatol 23:203–205PubMedCrossRef Freire Ade L, Bertolo MB, de Pinho AJ Jr et al (2004) Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet’s disease. Clin Rheumatol 23:203–205PubMedCrossRef
42.
Zurück zum Zitat Del Vecchio GC, Penza R, Altomare M et al (2008) Cytokine pattern and endothelium damage markers in Henoch-Schönlein purpura. Immunopharmacol Immunotoxicol 30:623–629PubMedCrossRef Del Vecchio GC, Penza R, Altomare M et al (2008) Cytokine pattern and endothelium damage markers in Henoch-Schönlein purpura. Immunopharmacol Immunotoxicol 30:623–629PubMedCrossRef
43.
Zurück zum Zitat Pober JS, Sessa WC (2007) Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7:803–815PubMedCrossRef Pober JS, Sessa WC (2007) Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7:803–815PubMedCrossRef
44.
Zurück zum Zitat Akdogan A, Calguneri M, Yavuz B et al (2006) Are Familial Mediterranean Fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 48:2351–2353PubMedCrossRef Akdogan A, Calguneri M, Yavuz B et al (2006) Are Familial Mediterranean Fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 48:2351–2353PubMedCrossRef
45.
Zurück zum Zitat Terekeci HM, Oktenli C, Ozgurtas T et al (2008) Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? J Rheumatol 35:2024–2029PubMed Terekeci HM, Oktenli C, Ozgurtas T et al (2008) Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? J Rheumatol 35:2024–2029PubMed
46.
Zurück zum Zitat Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP et al (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8:437–449PubMedCrossRef Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP et al (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8:437–449PubMedCrossRef
47.
Zurück zum Zitat Aksu G, Ozturk C, Kavakli K et al (2007) Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever. Clin Rheumatol 26:366–370PubMedCrossRef Aksu G, Ozturk C, Kavakli K et al (2007) Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever. Clin Rheumatol 26:366–370PubMedCrossRef
48.
Zurück zum Zitat Demirel A, Celkan T, Kasapcopur O et al (2008) Is Familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr 167:279–285PubMedCrossRef Demirel A, Celkan T, Kasapcopur O et al (2008) Is Familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr 167:279–285PubMedCrossRef
49.
Zurück zum Zitat Aoun EG, Musallam KM, Uthman I et al (2009) Childhood stroke in a child with familial Mediterranean fever carrying several prothrombotic risk factors. Lupus 18:845–847PubMedCrossRef Aoun EG, Musallam KM, Uthman I et al (2009) Childhood stroke in a child with familial Mediterranean fever carrying several prothrombotic risk factors. Lupus 18:845–847PubMedCrossRef
50.
Zurück zum Zitat Sari S, Egritas O, Bukulmez A et al (2009) Is familial mediterranean fever a possible cofactor for budd-chiari syndrome? J Pediatr Gastroenterol Nutr 49:481–484PubMedCrossRef Sari S, Egritas O, Bukulmez A et al (2009) Is familial mediterranean fever a possible cofactor for budd-chiari syndrome? J Pediatr Gastroenterol Nutr 49:481–484PubMedCrossRef
51.
Zurück zum Zitat Ozel Demiralp DF, Ekim M, Akar N (2009) The effect of plasminogen activator inhibitor-1–675 4G/5G polymorphism on Familial Mediterranean Fever (FMF) Disease. Clin Appl Thromb Hemost 15:443–447PubMedCrossRef Ozel Demiralp DF, Ekim M, Akar N (2009) The effect of plasminogen activator inhibitor-1–675 4G/5G polymorphism on Familial Mediterranean Fever (FMF) Disease. Clin Appl Thromb Hemost 15:443–447PubMedCrossRef
52.
Zurück zum Zitat Serrano R, Martínez MA, Andrés A et al (1998) Familial mediterranean fever and acute myocardial infarction secondary to coronary vasculitis. Histopathology 33:163–167PubMedCrossRef Serrano R, Martínez MA, Andrés A et al (1998) Familial mediterranean fever and acute myocardial infarction secondary to coronary vasculitis. Histopathology 33:163–167PubMedCrossRef
53.
Zurück zum Zitat Cocco G (2008) Vasculitis, left bundle branch block, and Raynaud’s phenomenon as a manifestation of familial Mediterranean fever. Arch Med Sci 4:460–464 Cocco G (2008) Vasculitis, left bundle branch block, and Raynaud’s phenomenon as a manifestation of familial Mediterranean fever. Arch Med Sci 4:460–464
54.
Zurück zum Zitat Efthimiou P, Flavell RA, Furlan A et al (2008) Autoinflammatory syndromes and infections: pathogenetic and clinical implications. Clin Exp Rheumatol 26(1 Suppl 48):S53–S61PubMed Efthimiou P, Flavell RA, Furlan A et al (2008) Autoinflammatory syndromes and infections: pathogenetic and clinical implications. Clin Exp Rheumatol 26(1 Suppl 48):S53–S61PubMed
55.
Zurück zum Zitat Tekin M, Yalcinkaya F, Tumer N (1999) Familial mediterranean fever and acute rheumatic fever: a pathogenetic relationship? Clin Rheumatol 18:446–449PubMedCrossRef Tekin M, Yalcinkaya F, Tumer N (1999) Familial mediterranean fever and acute rheumatic fever: a pathogenetic relationship? Clin Rheumatol 18:446–449PubMedCrossRef
56.
Zurück zum Zitat Yalcinkaya F, Ince E, Ucar T et al (2002) Antistreptococcal response is exaggerated in children with familial Mediterranean fever. Clin Rheumatol 21:378–381PubMedCrossRef Yalcinkaya F, Ince E, Ucar T et al (2002) Antistreptococcal response is exaggerated in children with familial Mediterranean fever. Clin Rheumatol 21:378–381PubMedCrossRef
57.
Zurück zum Zitat David J, Ansell BM, Woo P (1993) Polyarteritis nodosa associated with streptococcus. Arch Dis Child 69:685–688PubMedCrossRef David J, Ansell BM, Woo P (1993) Polyarteritis nodosa associated with streptococcus. Arch Dis Child 69:685–688PubMedCrossRef
58.
Zurück zum Zitat Cimolai N, Macnab A (1991) Schonlein-Henoch purpura and Streptococcus equisimilis. Br J Dermatol 125:403PubMedCrossRef Cimolai N, Macnab A (1991) Schonlein-Henoch purpura and Streptococcus equisimilis. Br J Dermatol 125:403PubMedCrossRef
59.
Zurück zum Zitat Masuda M, Nakanishi K, Yoshizawa N et al (2003) Group A streptococcal antigen in the glomeruli of children with Henoch-Schönlein nephritis. Am J Kidney Dis 41:366–370PubMedCrossRef Masuda M, Nakanishi K, Yoshizawa N et al (2003) Group A streptococcal antigen in the glomeruli of children with Henoch-Schönlein nephritis. Am J Kidney Dis 41:366–370PubMedCrossRef
60.
Zurück zum Zitat Soylu A, Kasap B, Türkmen M et al (2006) Febrile myalgia syndrome in familial Mediterranean fever. J Clin Rheumatol 12:93–96PubMedCrossRef Soylu A, Kasap B, Türkmen M et al (2006) Febrile myalgia syndrome in familial Mediterranean fever. J Clin Rheumatol 12:93–96PubMedCrossRef
61.
Zurück zum Zitat Candan F, Ayan S, Tas F et al (2005) Spontaneous renal laceration as the presenting feature of polyarteritis nodosa in a patient with familial Mediterranean fever after hepatitis A infection. Rheumatol Int 25:475–477PubMedCrossRef Candan F, Ayan S, Tas F et al (2005) Spontaneous renal laceration as the presenting feature of polyarteritis nodosa in a patient with familial Mediterranean fever after hepatitis A infection. Rheumatol Int 25:475–477PubMedCrossRef
63.
Zurück zum Zitat Gonzalez-Gay MA, Garcia-Porrua C (2002) Henoch-Schönlein Purpura. In: Ball GV, Bridges SL (eds) Vasculitis. Oxford University Press, New York, pp 476–494 Gonzalez-Gay MA, Garcia-Porrua C (2002) Henoch-Schönlein Purpura. In: Ball GV, Bridges SL (eds) Vasculitis. Oxford University Press, New York, pp 476–494
64.
65.
Zurück zum Zitat Tekin M, Yalcinkaya F, Tumer N et al (2000) Clinical, laboratory and molecular characteristics of children with Familial Mediterranean Fever-associated vasculitis. Acta Paediatr 89:177–182PubMedCrossRef Tekin M, Yalcinkaya F, Tumer N et al (2000) Clinical, laboratory and molecular characteristics of children with Familial Mediterranean Fever-associated vasculitis. Acta Paediatr 89:177–182PubMedCrossRef
66.
Zurück zum Zitat Gershoni-Baruch R, Broza Y, Brik R (2003) Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. J Pediatr 143:658–661PubMedCrossRef Gershoni-Baruch R, Broza Y, Brik R (2003) Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. J Pediatr 143:658–661PubMedCrossRef
67.
Zurück zum Zitat Colmegna I, Maldonado-Cocco JA (2005) Polyarteritis nodosa revisited. Curr Rheumatol Rep 7:288–296PubMedCrossRef Colmegna I, Maldonado-Cocco JA (2005) Polyarteritis nodosa revisited. Curr Rheumatol Rep 7:288–296PubMedCrossRef
68.
Zurück zum Zitat Levine SM, Hellmann DB, Stone JH (2002) Gastrointestinal involvement in polyarteritis nodosa (1986–2000): presentation and outcomes in 24 patients. Am J Med 112:386–391PubMedCrossRef Levine SM, Hellmann DB, Stone JH (2002) Gastrointestinal involvement in polyarteritis nodosa (1986–2000): presentation and outcomes in 24 patients. Am J Med 112:386–391PubMedCrossRef
69.
Zurück zum Zitat Michet CJ (1990) Polymyalgia rheumatica/giant cell arteritis and other vasculitides. Rheum Dis Clin North Am 16:667–680PubMed Michet CJ (1990) Polymyalgia rheumatica/giant cell arteritis and other vasculitides. Rheum Dis Clin North Am 16:667–680PubMed
70.
Zurück zum Zitat Ozen S, Ben-Chetrit E, Bakkaloglu A et al (2001) Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum 30:281–287PubMedCrossRef Ozen S, Ben-Chetrit E, Bakkaloglu A et al (2001) Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum 30:281–287PubMedCrossRef
71.
Zurück zum Zitat Akar S, Goktay Y, Akinci B et al (2005) A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizations. Rheumatol Int 25:60–64PubMedCrossRef Akar S, Goktay Y, Akinci B et al (2005) A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizations. Rheumatol Int 25:60–64PubMedCrossRef
72.
Zurück zum Zitat Bircan Z, Usluer H (2008) Protracted febrile myalgia mimicking polyarteritis nodosa. J Clin Rheumatol 14:222–225PubMed Bircan Z, Usluer H (2008) Protracted febrile myalgia mimicking polyarteritis nodosa. J Clin Rheumatol 14:222–225PubMed
73.
Zurück zum Zitat Tufan G, Demir S (2010) Uncommon clinical pattern of FMF: protracted febrile myalgia syndrome. Rheumatol Int 30:1089–1090PubMedCrossRef Tufan G, Demir S (2010) Uncommon clinical pattern of FMF: protracted febrile myalgia syndrome. Rheumatol Int 30:1089–1090PubMedCrossRef
74.
Zurück zum Zitat Sidi G, Shinar Y, Livneh A et al (2000) Protracted febrile myalgia of familial Mediterranean fever. Mutation analysis and clinical correlations. Scand J Rheumatol 29:174–176PubMedCrossRef Sidi G, Shinar Y, Livneh A et al (2000) Protracted febrile myalgia of familial Mediterranean fever. Mutation analysis and clinical correlations. Scand J Rheumatol 29:174–176PubMedCrossRef
75.
76.
Zurück zum Zitat La Regina M, Gasparyan AY, Orlandini F, Prisco D (2010) Behçet’s disease as a model of venous thrombosis. Open Cardiovasc Med J 23(4):71–77 La Regina M, Gasparyan AY, Orlandini F, Prisco D (2010) Behçet’s disease as a model of venous thrombosis. Open Cardiovasc Med J 23(4):71–77
77.
Zurück zum Zitat Schwartz T, Langevitz P, Zemer D et al (1997) Increased incidence of Behcet’s disease (BD) in familial Mediterranean fever (FMF). In: Sohar E, Gafni J, Pras M (eds) Familial mediterranean fever. Freund Publishing House, Tel-Aviv, pp 148–150 Schwartz T, Langevitz P, Zemer D et al (1997) Increased incidence of Behcet’s disease (BD) in familial Mediterranean fever (FMF). In: Sohar E, Gafni J, Pras M (eds) Familial mediterranean fever. Freund Publishing House, Tel-Aviv, pp 148–150
78.
Zurück zum Zitat Yurdakul S, Gunaydin I, Tuzun Y et al (1988) The prevalence of Behçet’s syndrome in a rural area in northern Turkey. J Rheumatol 15:820–822PubMed Yurdakul S, Gunaydin I, Tuzun Y et al (1988) The prevalence of Behçet’s syndrome in a rural area in northern Turkey. J Rheumatol 15:820–822PubMed
79.
Zurück zum Zitat Ben-Chetrit E, Cohen R, Chajek-Shaul T (2002) Familial Mediterranean fever and Behçet’s disease-are they associated? J Rheumatol 29:530–534PubMed Ben-Chetrit E, Cohen R, Chajek-Shaul T (2002) Familial Mediterranean fever and Behçet’s disease-are they associated? J Rheumatol 29:530–534PubMed
80.
Zurück zum Zitat Esen F, Celik A, Yazici H (2009) The use of diseased control groups in genetic association studies. Clin Exp Rheumatol 27(2 Suppl 53):S4–S5PubMed Esen F, Celik A, Yazici H (2009) The use of diseased control groups in genetic association studies. Clin Exp Rheumatol 27(2 Suppl 53):S4–S5PubMed
81.
Zurück zum Zitat Livneh A, Aksentijevich I, Langevitz P et al (2001) A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet’s disease (FMF-BD). Eur J Hum Genet 9:191–196PubMedCrossRef Livneh A, Aksentijevich I, Langevitz P et al (2001) A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet’s disease (FMF-BD). Eur J Hum Genet 9:191–196PubMedCrossRef
82.
Zurück zum Zitat Touitou I, Magne X, Molinari N et al (2000) MEFV mutations in Behçet’s disease. Hum Mutat 16:271–272PubMedCrossRef Touitou I, Magne X, Molinari N et al (2000) MEFV mutations in Behçet’s disease. Hum Mutat 16:271–272PubMedCrossRef
83.
Zurück zum Zitat Imirzalioglu N, Dursun A, Tastan B et al (2005) MEFV gene is a probable susceptibility gene for Behçet’s disease. Scand J Rheumatol 34:56–58PubMedCrossRef Imirzalioglu N, Dursun A, Tastan B et al (2005) MEFV gene is a probable susceptibility gene for Behçet’s disease. Scand J Rheumatol 34:56–58PubMedCrossRef
84.
Zurück zum Zitat Rabinovich E, Shinar Y, Leiba M et al (2007) Common FMF alleles may predispose to development of Behcet’s disease with increased risk for venous thrombosis. Scand J Rheumatol 36:48–52PubMedCrossRef Rabinovich E, Shinar Y, Leiba M et al (2007) Common FMF alleles may predispose to development of Behcet’s disease with increased risk for venous thrombosis. Scand J Rheumatol 36:48–52PubMedCrossRef
85.
Zurück zum Zitat Dursun A, Durakbasi-Dursun HG, Zamani AG et al (2006) Genetic analysis of MEFV gene pyrin domain in patients with Behçet’s disease. Mediators Inflamm 41783(3):1–4CrossRef Dursun A, Durakbasi-Dursun HG, Zamani AG et al (2006) Genetic analysis of MEFV gene pyrin domain in patients with Behçet’s disease. Mediators Inflamm 41783(3):1–4CrossRef
86.
Zurück zum Zitat Espinosa G, Arostegui JI, Plaza S et al (2005) Behçet’s disease and hereditary periodic fever syndromes: casual association or causal relationship? Clin Exp Rheumatol 23(4 Suppl 38):S64–S66PubMed Espinosa G, Arostegui JI, Plaza S et al (2005) Behçet’s disease and hereditary periodic fever syndromes: casual association or causal relationship? Clin Exp Rheumatol 23(4 Suppl 38):S64–S66PubMed
87.
Zurück zum Zitat Schlesinger M, Kopolovic J, Viskoper RJ, Ron N (1983) A case of familial Mediterranean fever with cutaneous vasculitis and immune complex nephritis: light, electron, and immunofluorescent study of renal biopsy. Am J Clin Pathol 80:511–514PubMed Schlesinger M, Kopolovic J, Viskoper RJ, Ron N (1983) A case of familial Mediterranean fever with cutaneous vasculitis and immune complex nephritis: light, electron, and immunofluorescent study of renal biopsy. Am J Clin Pathol 80:511–514PubMed
88.
Zurück zum Zitat Barzilai A, Langevitz P, Goldberg I et al (2000) Erysipelas-like erythema of familial mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol 42:791–795PubMedCrossRef Barzilai A, Langevitz P, Goldberg I et al (2000) Erysipelas-like erythema of familial mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol 42:791–795PubMedCrossRef
Metadaten
Titel
Coexistence of vasculitides with Familial Mediterranean Fever
verfasst von
Kenan Aksu
Gokhan Keser
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 10/2011
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1840-z

Weitere Artikel der Ausgabe 10/2011

Rheumatology International 10/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.